Caidya
The Future-Ready CRO
Raleigh · Founded 2021 · $165.0M raised
- Headquarters
- Raleigh
- Employees
- 1001–5000
- Founded
- 2021
- Business Model
- B2B
- Website
- caidya.com
- Total Funding
- $165.0M
- Last Round
- $165.0M Growth EquityJan 2025
- Rounds
- 1
About
Caidya is a global full-service contract research organization (CRO) formed in 2021 from the merger of dMed and Clinipace. With nearly 1,800 employees across 30+ countries, Caidya supports biopharma innovators from pre-IND strategy through clinical development, submission, and post-marketing surveillance, with deep expertise in oncology, rare disease, and cross-border trials.
Summary
Caidya is a Biotech company based in Raleigh, founded in 2021. It has raised $165.0M in total across 1 round, most recently a $165.0M Growth Equity round in Jan 2025. Investors include Rubicon Founders.
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company

Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...